文献速递免疫规划传染病防控与疫情报告

2016/17流感季西班牙瓦伦西亚地区60岁及以上人群流感疫苗预防实验室确诊流感住院的效果

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.
PubMed 文献 · Euro Surveill · 2018-01-01

在西班牙瓦伦西亚医院监测网络开展的多中心前瞻性研究中,采用检测阴性设计评估60岁及以上人群流感疫苗效果。调整后疫苗效果为19%(95%CI:-15至43);当季接种且前两季未接种者效果为49%(95%CI:-20至78),当季及前两季任一时段接种者效果为29%(95%CI:-3至52),当季未接种但前两季任一时段接种者效果为53%(95%CI:8至76)。数据显示2016/17流感季疫苗效果较低。

要点

  • 调整后流感疫苗效果为19%(95%CI:-15至43)。
  • 当季接种且前两季未接种者效果为49%(95%CI:-20至78)。
  • 当季未接种但前两季任一时段接种者效果为53%(95%CI:8至76)。

核心结论

  • 数据显示2016/17流感季流感疫苗效果较低。

研究设计与样本

  • 西班牙瓦伦西亚医院流感与呼吸道病毒疾病研究监测网络(VAHNSI)的多中心前瞻性研究。
  • 研究对象为60岁及以上人群,采用检测阴性设计,以实验室确诊流感为结局、接种状态为暴露。
  • 潜在混杂因素信息来自临床登记或直接取自患者。

主要发现

  • 调整后疫苗效果为19%(95%CI:-15至43)。
  • 当季接种且前两季未接种者效果为49%(95%CI:-20至78)。
  • 当季及前两季任一时段接种者效果为29%(95%CI:-3至52)。
  • 当季未接种但前两季任一时段接种者效果为53%(95%CI:8至76)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IntroductionSeasonal influenza vaccination is widely recommended for people with risk factors, especially for people who are elderly. However, influenza vaccine effectiveness (IVE) varies year after year because of the variable antigenic composition of the circulating viruses and the vaccine composition. Methods: We summarise the results of IVE and the impact of previous vaccination among subjects 60 years of age and over in a multicentre prospective study in the Valencia Hospital Surveillance Network for the Study of Influenza and Respiratory Viruses Disease (VAHNSI) in Spain. We applied the test-negative design taking laboratory-confirmed influenza as outcome and vaccination status as exposure. Information about potential confounders was obtained from clinical registries or directly from patients. Results: Adjusted IVE was 19% (95% confidence interval (CI): -15 to 43). For patients vaccinated in the current season but not in the two previous seasons, effectiveness was 49% (95% CI: -20 to 78) and for patients vaccinated in the current and any of two previous seasons, effectiveness was 29% (95% CI: -3 to 52). For those patients not vaccinated in the current season but vaccinated in any of the two previous seasons, effectiveness was 53% (95% CI: 8 to 76). Conclusions: Our data show a low vaccine effectiveness for the 2016/17 influenza season.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Mira-Iglesias A, López-Labrador FX, Guglieri-López B, et al. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17. Euro Surveill. 2018. PMID: 29486829. doi:10.2807/1560-7917.ES.2018.23.8.17-00318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。